• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺上皮内瘤变:增殖细胞核抗原在上皮、内皮及基质细胞核中的表达与定位

Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.

作者信息

Montironi R, Galluzzi C M, Diamanti L, Giannulis I, Pisani E, Scarpelli M

机构信息

Institute of Morbid Anatomy and Histopathology, University of Ancona, Nuovo Ospedale Regionale, Torrette di Ancona, Italy.

出版信息

Virchows Arch A Pathol Anat Histopathol. 1993;422(3):185-92. doi: 10.1007/BF01621801.

DOI:10.1007/BF01621801
PMID:7684168
Abstract

The expression and location of proliferating cell nuclear antigen (PCNA) immunostaining in epithelial, endothelial and stromal nuclei were assessed in prostatic intra-epithelial neoplasia (PIN). It was then compared with patterns in benign lesions and in invasive adenocarcinomas of the prostate. The PCNA-positive nuclei showed homogeneous or granular types of staining, or a mixture of both, and a gradation in the intensity of staining. Nuclei with granular and mixed patterns appeared lighter brown than those with a homogeneous pattern, which are darker and more often noted in PIN and invasive adenocarcinomas than in benign lesions. For epithelial PCNA-stained nuclei, the proportions in the two grades of PIN were greater than in benign prostatic hyperplasia (mean 3.16%, SE 0.31%) and prostatic atrophic ducts and acini (mean 0.56%, SE 0.09%), the values decreasing from the nuclei in the basal position towards those in the luminal layer. In grade 1, the category mean values were 9.51% (SE 1.14%) in the basal, 7.02% (SE 1.27%) in the intermediate and 6.02% (SE 0.90%) in the luminal position. In grade 2, the category mean values were 13.81% (SE 1.42%) in the basal position, 10.99% (SE 1.17%) in the intermediate and 7.91% (SE 1.43%) in the luminal position. In small and large acinar adenocarcinomas, the proportions of positive nuclei were 8.66% (SE 0.30%) and 9.06% (SE 0.30%), respectively. The category mean values in the cribriform adenocarcinomas were 14.40% (SE 0.61%) in the basal position, 11.84% (SE 1.30%) in the intermediate and 9.26% (SE 0.66%) in the luminal position. As in PIN, the proportions of immunostained nuclei in the adenocarcinoma with cribriform pattern decreased from the basal towards the luminal layer. In the solid/trabecular adenocarcinomas, the category mean value in the cell layer adjacent to the stroma was 17.60% (SE 2.92%), whereas in the other cell layers it was lower than that in the cells adjacent the stroma (mean 13.88%, SE 1.71%). For capillary endothelial and stromal cells, the percentages of PCNA-stained nuclei were much lower than those in the epithelial component. The lowest mean values were obtained in benign lesions, whereas the highest were in invasive adenocarcinomas, the percentages in PIN being intermediate.

摘要

在前列腺上皮内瘤变(PIN)中评估增殖细胞核抗原(PCNA)免疫染色在上皮细胞核、内皮细胞核和基质细胞核中的表达及定位。然后将其与前列腺良性病变和浸润性腺癌中的模式进行比较。PCNA阳性细胞核呈现均匀或颗粒状染色类型,或两者混合,且染色强度有梯度变化。具有颗粒状和混合模式的细胞核比具有均匀模式的细胞核颜色浅,均匀模式的细胞核颜色更深,且在PIN和浸润性腺癌中比在良性病变中更常见。对于上皮PCNA染色的细胞核,PIN两级中的比例高于良性前列腺增生(平均3.16%,标准误0.31%)和前列腺萎缩性导管及腺泡(平均0.56%,标准误0.09%),从基底位置的细胞核到管腔层的细胞核,该值逐渐降低。在1级中,基底类别平均值为9.51%(标准误1.14%),中间为7.02%(标准误1.27%),管腔位置为6.02%(标准误0.90%)。在2级中,基底位置类别平均值为13.81%(标准误1.42%),中间为10.99%(标准误1.17%),管腔位置为7.91%(标准误1.43%)。在小腺泡腺癌和大腺泡腺癌中,阳性细胞核的比例分别为8.66%(标准误0.30%)和9.06%(标准误0.30%)。筛状腺癌中各类别平均值在基底位置为14.40%(标准误0.61%),中间为11.84%(标准误1.30%),管腔位置为9.26%(标准误0.66%)。与PIN一样,筛状模式腺癌中免疫染色细胞核的比例从基底到管腔层逐渐降低。在实性/小梁状腺癌中,与基质相邻的细胞层类别平均值为17.60%(标准误2.92%),而在其他细胞层低于与基质相邻的细胞(平均13.88%,标准误1.71%)。对于毛细血管内皮细胞和基质细胞,PCNA染色细胞核的百分比远低于上皮成分中的百分比。良性病变中获得的平均值最低,而浸润性腺癌中最高,PIN中的百分比介于两者之间。

相似文献

1
Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei.前列腺上皮内瘤变:增殖细胞核抗原在上皮、内皮及基质细胞核中的表达与定位
Virchows Arch A Pathol Anat Histopathol. 1993;422(3):185-92. doi: 10.1007/BF01621801.
2
Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.
Virchows Arch A Pathol Anat Histopathol. 1993;423(5):351-7. doi: 10.1007/BF01607147.
3
Prostatic invasive adenocarcinoma. Effect of combination endocrine therapy (LHRH agonist and flutamide) on the expression and location of proliferating cell nuclear antigen (PCNA).前列腺浸润性腺癌。联合内分泌治疗(促性腺激素释放激素激动剂和氟他胺)对增殖细胞核抗原(PCNA)表达及定位的影响。
Pathol Res Pract. 1993 Dec;189(10):1154-60. doi: 10.1016/S0344-0338(11)80838-1.
4
Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part?增殖细胞核抗原(PCNA)在前列腺浸润性腺癌中的表达。肿瘤边缘区的增殖状态是否高于中央区?
Anticancer Res. 1993 Jan-Feb;13(1):129-32.
5
Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN).前列腺上皮内瘤变(PIN)中分裂象的频率及位置
Anticancer Res. 1993 Nov-Dec;13(6B):2447-51.
6
Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.前列腺上皮内瘤变中IV型胶原酶(72-kd金属蛋白酶)的免疫组织化学评估
Anticancer Res. 1996 Jul-Aug;16(4A):2057-62.
7
Proliferating cell nuclear antigen (PCNA) evaluation in the diagnostic quantitative pathology of cribriform adenocarcinoma of the prostate.增殖细胞核抗原(PCNA)在前列腺筛状腺癌诊断性定量病理学中的评估
In Vivo. 1993 Jul-Aug;7(4):343-6.
8
Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.基底细胞的局灶性变性及由此产生的自身免疫反应:前列腺肿瘤进展和侵袭的新机制。
Med Hypotheses. 2008;70(2):387-408. doi: 10.1016/j.mehy.2007.05.015. Epub 2007 Jul 20.
9
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.前列腺干细胞区室:细胞周期抑制剂p27Kip1在正常、增生和肿瘤细胞中的表达
Am J Pathol. 1998 Sep;153(3):911-9. doi: 10.1016/S0002-9440(10)65632-5.
10
Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.腺病中的细胞增殖、凋亡、癌基因和肿瘤抑制基因状态,并与良性前列腺增生、前列腺上皮内瘤变和癌症进行比较。
Hum Pathol. 1999 Sep;30(9):1077-86. doi: 10.1016/s0046-8177(99)90226-5.

引用本文的文献

1
Molecular pathogenesis of human prostate basal cell hyperplasia.人类前列腺基底细胞增生的分子发病机制
Prostate. 2017 May;77(13):1344-1355. doi: 10.1002/pros.23394. Epub 2017 Aug 10.
2
DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.DNA复制调控蛋白Mcm7作为前列腺癌增殖的标志物
J Clin Pathol. 2004 Oct;57(10):1057-62. doi: 10.1136/jcp.2004.016436.
3
Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.Bcl-2表达与前列腺癌中雄激素受体、p21WAF1/CIP1及细胞周期蛋白D1状态的关系

本文引用的文献

1
Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections.
Pathol Res Pract. 1993 Jun;189(5):542-8.
2
The biological significance of atypical hyperplasia of the prostate.前列腺非典型增生的生物学意义。
Virchows Arch A Pathol Anat Histol. 1980;387(3):307-17. doi: 10.1007/BF00454834.
3
Endothelial proliferation in tumours and normal tissues: continuous labelling studies.肿瘤与正常组织中的内皮细胞增殖:连续标记研究
Mol Pathol. 2000 Feb;53(1):15-8. doi: 10.1136/mp.53.1.15.
4
Precursor lesions for prostate cancer.前列腺癌的前驱病变。
J R Soc Med. 1997 Oct;90(10):533-9. doi: 10.1177/014107689709001003.
5
Ki-67 expression in early prostate cancer and associated pathological lesions.Ki-67在早期前列腺癌及相关病理病变中的表达
J Clin Pathol. 1996 Sep;49(9):741-8. doi: 10.1136/jcp.49.9.741.
6
Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.细胞角蛋白mRNA和蛋白在正常前列腺、前列腺上皮内瘤变及浸润性癌中的差异表达
Am J Pathol. 1997 Feb;150(2):693-704.
7
The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.非典型腺瘤样增生和前列腺上皮内瘤变在前列腺癌发生发展中的意义。最新进展。
Virchows Arch. 1995;426(5):425-34. doi: 10.1007/BF00193163.
8
Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.联合内分泌治疗对正常前列腺、前列腺上皮内瘤变和前列腺腺癌的影响。
J Clin Pathol. 1994 Oct;47(10):906-13. doi: 10.1136/jcp.47.10.906.
9
Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia.
Virchows Arch A Pathol Anat Histopathol. 1993;423(5):351-7. doi: 10.1007/BF01607147.
Br J Cancer. 1984 Apr;49(4):405-13. doi: 10.1038/bjc.1984.66.
4
Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder.血管生成活性作为人类膀胱肿瘤性和癌前病变的标志物。
Ann Surg. 1980 Dec;192(6):762-71. doi: 10.1097/00000658-198012000-00012.
5
Tumor angiogenesis. Rapid induction of endothelial mitoses demonstrated by autoradiography.肿瘤血管生成。通过放射自显影术显示内皮细胞有丝分裂的快速诱导。
J Cell Biol. 1972 Aug;54(2):408-20. doi: 10.1083/jcb.54.2.408.
6
Intraductal dysplasia: a premalignant lesion of the prostate.导管内发育异常:前列腺的一种癌前病变。
Hum Pathol. 1986 Jan;17(1):64-71. doi: 10.1016/s0046-8177(86)80156-3.
7
Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining.通过Ki-67免疫染色测定人前列腺癌中的生长分数。
J Pathol. 1988 Oct;156(2):161-7. doi: 10.1002/path.1711560211.
8
Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.培养细胞中核蛋白细胞周期蛋白增殖细胞核抗原分布的细胞周期依赖性变化:S期的细分
Proc Natl Acad Sci U S A. 1985 May;82(10):3262-6. doi: 10.1073/pnas.82.10.3262.
9
Multiparametric quantitation of the progression of uterine cervix preneoplasia towards neoplasia.
Pathol Res Pract. 1989 Nov;185(5):606-11. doi: 10.1016/s0344-0338(89)80203-1.
10
Regulation of proliferating cell nuclear antigen during the cell cycle.细胞周期中增殖细胞核抗原的调控
J Biol Chem. 1989 Aug 15;264(23):13856-64.